PRESS RELEASE
News
-
-
PRESS RELEASE
VALBIOTIS SA: Valbiotis announces the success of its €6.9 million rights issue entirely dedicated to supporting the commercial expansion of its offering of dietary supplements
Valbiotis successfully completes €6.9 million rights issue to enhance commercial expansion of dietary supplements. Sébastien Peltier shows renewed commitment -
PRESS RELEASE
VALBIOTIS SA: Valbiotis announces the success of its €6.9 million rights issue entirely dedicated to supporting the commercial expansion of its offering of dietary supplements
Valbiotis announces success of €6.9 million rights issue to support commercial expansion of dietary supplements. Strong interest from shareholders -
PRESS RELEASE
VALBIOTIS SA: Valbiotis annonce le succès de son augmentation de capital de 6,9 M€ entièrement dédiée à soutenir l’expansion commerciale de son offre de compléments alimentaires
Valbiotis annonce le succès de son augmentation de capital de 6,9 M€ pour l'expansion commerciale de ses compléments alimentaires. Sébastien PELTIER souscrit à l'opération -
-
-
-
PRESS RELEASE
VALBIOTIS SA: Valbiotis annonce le lancement d’une augmentation de capital avec maintien du DPS d’un montant de 6,9 M€ sécurisée par des engagements à hauteur de 75,0%
Valbiotis SA annonce une augmentation de capital de 6,9 M€ avec maintien du DPS sécurisée par des engagements à 75,0% pour financer sa stratégie commerciale et son développement. Prix de souscription à 0,88 € par action -
PRESS RELEASE
VALBIOTIS SA: Valbiotis announces the launch of a capital increase with maintained preferential subscription rights for a gross amount of nearly €6.9 million, secured by subscription commitments of 75
Valbiotis announces a capital increase of nearly €6.9 million with preferential subscription rights, aiming to finance its commercial strategy and sales growth of health supplements. Subscription period from 12 to 24 June 2025 -
